Literature DB >> 23688441

The role of Stat3 in glioblastoma multiforme.

Rodney B Luwor1, Stanley S Stylli, Andrew H Kaye.   

Abstract

Glioblastoma multiforme (GBM) is the most common brain tumor and has the worst prognosis. Several signaling molecules have been clearly implicated in the development, progression, and aggressiveness of GBM. Here we review the role of signal transducer and activator of transcription-3 (Stat3) in GBM. We particularly focus on its expression in clinical GBM samples, its role in brain tumorigenicity in cell lines and animal models, and discuss possible therapeutic strategies targeting Stat3. This review also summarizes the current knowledge regarding the role of Stat3 regulation by upstream activators and repressors in promoting GBM progression in both translational and clinical studies.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23688441     DOI: 10.1016/j.jocn.2013.03.006

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  47 in total

1.  FoxM1 Drives a Feed-Forward STAT3-Activation Signaling Loop That Promotes the Self-Renewal and Tumorigenicity of Glioblastoma Stem-like Cells.

Authors:  Ai-Hua Gong; Ping Wei; Sicong Zhang; Jun Yao; Ying Yuan; Ai-Dong Zhou; Frederick F Lang; Amy B Heimberger; Ganesh Rao; Suyun Huang
Journal:  Cancer Res       Date:  2015-04-01       Impact factor: 12.701

2.  Prostaglandin E2 triggers cytochrome P450 17α hydroxylase overexpression via signal transducer and activator of transcription 3 phosphorylation and promotes invasion in endometrial cancer.

Authors:  Jieqi Ke; Zhen Shen; Min Li; Cheng Peng; Ping Xu; Meimei Wang; Yi Zhu; Xuefen Zhang; Dabao Wu
Journal:  Oncol Lett       Date:  2018-07-18       Impact factor: 2.967

3.  Combined Inhibition of HDAC and EGFR Reduces Viability and Proliferation and Enhances STAT3 mRNA Expression in Glioblastoma Cells.

Authors:  Marienela Buendia Duque; Kelly de Vargas Pinheiro; Amanda Thomaz; Camila Alves da Silva; Natália Hogetop Freire; André Tesainer Brunetto; Gilberto Schwartsmann; Mariane Jaeger; Caroline Brunetto de Farias; Rafael Roesler
Journal:  J Mol Neurosci       Date:  2019-03-18       Impact factor: 3.444

4.  Oxaliplatin disrupts pathological features of glioma cells and associated macrophages independent of apoptosis induction.

Authors:  Nathan B Roberts; Aymen Alqazzaz; Jacqueline R Hwang; Xiulan Qi; Achsah D Keegan; Anthony J Kim; Jeffrey A Winkles; Graeme F Woodworth
Journal:  J Neurooncol       Date:  2018-08-21       Impact factor: 4.130

5.  Nuclear factor erythroid 2-related factor 2 enhances carcinogenesis by suppressing apoptosis and promoting autophagy in nickel-transformed cells.

Authors:  Young-Ok Son; Poyil Pratheeshkumar; Sasidharan Padmaja Divya; Zhuo Zhang; Xianglin Shi
Journal:  J Biol Chem       Date:  2017-03-22       Impact factor: 5.157

6.  Epithelial membrane protein-2 (EMP2) promotes angiogenesis in glioblastoma multiforme.

Authors:  Yu Qin; Masamichi Takahashi; Kristopher Sheets; Horacio Soto; Jessica Tsui; Panayiotis Pelargos; Joseph P Antonios; Noriyuki Kasahara; Isaac Yang; Robert M Prins; Jonathan Braun; Lynn K Gordon; Madhuri Wadehra
Journal:  J Neurooncol       Date:  2017-06-09       Impact factor: 4.130

7.  Protein Analysis of Glioblastoma Primary and Posttreatment Pairs Suggests a Mesenchymal Shift at Recurrence.

Authors:  Matthew D Wood; Gerald F Reis; David E Reuss; Joanna J Phillips
Journal:  J Neuropathol Exp Neurol       Date:  2016-08-18       Impact factor: 3.685

8.  Comprehensive characterization of glioblastoma tumor tissues for biomarker identification using mass spectrometry-based label-free quantitative proteomics.

Authors:  Maxime S Heroux; Marla A Chesnik; Brian D Halligan; Mona Al-Gizawiy; Jennifer M Connelly; Wade M Mueller; Scott D Rand; Elizabeth J Cochran; Peter S LaViolette; Mark G Malkin; Kathleen M Schmainda; Shama P Mirza
Journal:  Physiol Genomics       Date:  2014-05-06       Impact factor: 3.107

9.  Quantitative proteomic analysis reveals effects of epidermal growth factor receptor (EGFR) on invasion-promoting proteins secreted by glioblastoma cells.

Authors:  Vineet Sangar; Cory C Funk; Ulrike Kusebauch; David S Campbell; Robert L Moritz; Nathan D Price
Journal:  Mol Cell Proteomics       Date:  2014-07-05       Impact factor: 5.911

10.  Inhibition of glioblastoma cell proliferation, migration and invasion by the proteasome antagonist carfilzomib.

Authors:  Zammam Areeb; Stanley S Stylli; Thomas M B Ware; Nicole C Harris; Lipi Shukla; Ramin Shayan; Lucia Paradiso; Bo Li; Andrew P Morokoff; Andrew H Kaye; Rodney B Luwor
Journal:  Med Oncol       Date:  2016-04-20       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.